Bank of New York Mellon Corp
BankPosition in RLMD — Relmada Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in RLMD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,045,709
+$1,999,350 QoQ
Shares Held
295,623
+2540.0% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 126 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. RLMD ranks #150 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in RLMD
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,045,709 | 295,623 | Shares | Defined | 2026-08-06 | |
| 2023-12-31 | $46,359 | 11,198 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $110,157 | 36,719 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $195,392 | 79,428 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $346,915 | 153,503 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $649,703 | 186,162 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,954,707 | 214,876 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $4,595,939 | 242,019 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,396,979 | 237,013 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $4,795,779 | 212,862 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,187,848 | 197,934 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $6,373,958 | 199,124 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $6,673,843 | 189,544 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $5,295,365 | 165,119 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $6,677,511 | 177,499 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $5,926,286 | 132,431 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $3,347,690 | 98,144 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||